PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. (Record no. 26946135)

MARC details
000 -LEADER
fixed length control field 02322 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517142529.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201806s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1557-3265
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1158/1078-0432.CCR-16-2601
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Melaiu, Ombretta
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180619
245 00 - TITLE STATEMENT
Title PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical cancer research : an official journal of the American Association for Cancer Research
Date of publication, distribution, etc. Aug 2017
300 ## - PHYSICAL DESCRIPTION
Extent 4462-4472 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, CD
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Azepines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element B7-H1 Antigen
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child, Preschool
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gene Expression Regulation, Neoplastic
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genes, MHC Class I
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infant
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphocytes, Tumor-Infiltrating
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Targeted Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element N-Myc Proto-Oncogene Protein
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuroblastoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Programmed Cell Death 1 Receptor
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins c-myc
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphocyte Activation Gene 3 Protein
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mina, Marco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chierici, Marco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boldrini, Renata
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jurman, Giuseppe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Romania, Paolo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name D'Alicandro, Valerio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Benedetti, Maria C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Castellano, Aurora
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liu, Tao
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Furlanello, Cesare
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Locatelli, Franco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fruci, Doriana
773 0# - HOST ITEM ENTRY
Title Clinical cancer research : an official journal of the American Association for Cancer Research
Related parts vol. 23
-- no. 15
-- p. 4462-4472
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1158/1078-0432.CCR-16-2601">https://doi.org/10.1158/1078-0432.CCR-16-2601</a>
Public note Available from publisher's website

No items available.